You are here: Industry Insights > Cancer

News List

CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData expresspharma
March 15, 2021
Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas Medicine.
NHS England breast cancer wait times are ‘deeply worrying’ pharmatimes
March 12, 2021
NHS England cancer waiting times data from January shows that all targets for breast cancer have been missed, including two week wait targets as well as 31 day and 62 day targets.
Researchers identify early changes in BRCA1-positive breast cells pharmatimes
March 10, 2021
A new study has found that BRCA1-positive breast cells appear to undergo changes before becoming cancerous, which could help identify which patients can benefit from preventative surgery.
Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer prnasia
March 09, 2021
Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies for the treatment of cancer, announced that it has entered into an exclusive license and collaboration agreement with Shanghai-based ...
GeoVax Expands Intellectual Property Portfolio americanpharmaceuticalreview
March 09, 2021
GeoVax Labs announced the filing of two additional patent applications important to the Company’s key focus on vaccines against SARS-CoV-2 (COVID-19) and cancer immunotherapies.
Radiotherapy responses may be improved with targeted immunotherapy, study suggests pharmatimes
March 08, 2021
A new study suggests that targeted immunotherapy could make cancers that are resistant to radiotherapy more responsive to treatment.
Launch of generic oncology medications to improve treatment access in India europeanpharmaceuticalreview
March 04, 2021
GlobalData suggests the recent approval of new generics in oncology should enhance access and adherence to cancer treatment by reducing costs borne by patients.
Elicio Announces IND for Vaccine Targeting Mutated KRAS Cancers americanpharmaceuticalreview
March 01, 2021
Elicio Therapeutics has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for ELI-002. ELI-002 is an Amphiphile (AMP) KRAS therapeutic vaccine containing AMP mKRAS peptides and a proprietary AMP CpG ...
Elekta establishes office in Egypt to meet growing need for precision radiation medicine prnasia
February 22, 2021
Elekta (EKTA-B.ST) announced today that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders.
Therapeutic proteins and oral vaccines market to surpass $300,000mn by 2027 europeanpharmaceuticalreview
February 19, 2021
The market is expected to grow at a 6.7 percent CAGR, driven by the increasing prevalence of cancer and cardiovascular diseases, as well as growing interest in biologics.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page